Lazard Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
BIP
Lazard Asset Management's PBH Position: Q2 2026 in Review
Lazard Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 6,993 shares — an estimated $414K sold.
Lazard Asset Management first reported a position in PBH in Q2 2020 and held it in 19 quarters. The position peaked at $7.57M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Lazard Asset Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
- Lazard Asset Management sold 6,993 Prestige Consumer Healthcare shares in Q2 2026, an estimated $414K.
- Lazard Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2020 and held it in 19 quarters.
- Lazard Asset Management's Prestige Consumer Healthcare position peaked at $7.57M in Q1 2025.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.